Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * # CSS, JS, Images Allow: /core/*.css$ Allow: /core/*.css? Allow: /core/*.js$ Allow: /core/*.js? Allow: /core/*.gif Allow: /core/*.jpg Allow: /core/*.jpeg Allow: /core/*.png Allow: /core/*.svg Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? Allow: /profiles/*.gif Allow: /profiles/*.jpg Allow: /profiles/*.jpeg Allow: /profiles/*.png Allow: /profiles/*.svg # Directories Disallow: /core/ Disallow: /profiles/ # Files Disallow: /README.txt Disallow: /web.config # Paths (clean URLs) Disallow: /admin/ Disallow: /comment/reply/ Disallow: /filter/tips Disallow: /node/add/ Disallow: /search/ Disallow: /user/* # Paths (no clean URLs) Disallow: /index.php/admin/ Disallow: /index.php/comment/reply/ Disallow: /index.php/filter/tips Disallow: /index.php/node/add/ Disallow: /index.php/search/ Disallow: /index.php/user/* #Sitemap sitemap.xml will be auto added at the end of this document. # XML sitemap. This string generated by id_custom |
Title | Homepage | |
Description | UNLEASHING IMMUNITY TO FIGHT BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug |
Keywords | N/A |
WebSite | bioinvent.com |
Host IP | 213.131.154.11 |
Location | Sweden |
Site | Rank |
US$3,759,300
Last updated: 2023-04-30 00:48:42
bioinvent.com has Semrush global rank of 2,815,499. bioinvent.com has an estimated worth of US$ 3,759,300, based on its estimated Ads revenue. bioinvent.com receives approximately 433,766 unique visitors each day. Its web server is located in Sweden, with IP address 213.131.154.11. According to SiteAdvisor, bioinvent.com is safe to visit. |
Purchase/Sale Value | US$3,759,300 |
Daily Ads Revenue | US$3,471 |
Monthly Ads Revenue | US$104,104 |
Yearly Ads Revenue | US$1,249,245 |
Daily Unique Visitors | 28,918 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
bioinvent.com. | A | 598 | IP: 213.131.154.11 |
bioinvent.com. | NS | 600 | NS Record: c.ns14.net. |
bioinvent.com. | NS | 600 | NS Record: b.ns14.net. |
bioinvent.com. | NS | 600 | NS Record: a.ns14.net. |
bioinvent.com. | NS | 600 | NS Record: d.ns14.net. |
bioinvent.com. | MX | 600 | MX Record: 10 mail.bioinvent.se. |
bioinvent.com. | TXT | 600 | TXT Record: CldBEK5sd3bJwoCrXbkO1p/WBid/gdKq+Sh3HlgFPQ7s2pE8P0R9gaDaFn3OfuFUzaCVLzNT1kh3VNH2M/Hm8g== |
bioinvent.com. | TXT | 600 | TXT Record: v=spf1 a:mail.bioinvent.se ip4:85.235.1.23/32 include:spf.protection.outlook.com -all |
bioinvent.com. | TXT | 600 | TXT Record: MS=ms53529197 |
Open menu Close menu Main Top Navigation Career Contacts About us Open link menu About us Working at BioInvent Management Board of Directors Our Operations Our Purpose & Strategy Our Stories Our History Portfolio strategy - five clinical programs BioInvent has a long history and a strong position in the generation and development of antibody drugs. The foundation of the company is expertise in immunology, cancer biology and antibody biology. Today, BioInvent is a company with multiple clinical programs ongoing. The unique development tool F.I.R.S.T™, where patient material is the foundation throughout the development process, simultaneously identifies the clinically most relevant targets in a disease model and matching antibodies. The proprietary antibody library n-CoDeR ® contains antibodies that bind specifically and strongly to their targets. Clinical programs Open link menu Clinical programs Pipeline Our Programs Open link menu Our Programs BI-1206 w rituximab BI-1206 w |
HTTP/1.1 301 Moved Permanently Content-Length: 145 Content-Type: text/html; charset=UTF-8 Location: https://bioinvent.com/ Server: Microsoft-IIS/10.0 X-Frame-Options: sameorigin X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Date: Fri, 22 Oct 2021 21:28:12 GMT HTTP/2 200 cache-control: private content-length: 34895 content-type: text/html; charset=utf-8 x-frame-options: sameorigin x-content-type-options: nosniff x-xss-protection: 1; mode=block date: Fri, 22 Oct 2021 21:28:13 GMT |
Domain Name: BIOINVENT.COM Registry Domain ID: 133127_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.psi-usa.info Registrar URL: http://www.psi-usa.info Updated Date: 2020-12-04T08:01:41Z Creation Date: 1996-12-04T05:00:00Z Registry Expiry Date: 2021-12-03T05:00:00Z Registrar: PSI-USA, Inc. dba Domain Robot Registrar IANA ID: 151 Registrar Abuse Contact Email: domain-abuse@psi-usa.info Registrar Abuse Contact Phone: +49.94159559482 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: A.NS14.NET Name Server: B.NS14.NET Name Server: C.NS14.NET Name Server: D.NS14.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T10:50:35Z <<< |